Richard G. Pestell, M.D., Ph.D.
Director Richard G. Pestell, M.D., Ph.D.
Dr. Richard G. Pestell
Richard G. Pestell completed his M.D. (1981) and Ph.D. degrees in Australia. He undertook post doctoral and clinical training in Hematology/Oncology and Endocrinology and continued research at Harvard University and served as Clinical fellow at Massachusetts General Hospital. He was the recipient of the Royal Australian College of Physicians Winthrop and Neil Hamilton Fairley awards (1991–1994). At Georgetown University he was Associate Vice President of Georgetown University Medical Center, Chairman of the Department of Oncology, and Director of the Lombardi Cancer Center from 2002-2005. He was Member, Board of Directors, Georgetown University Hospital and served on Medstar Health Boards (2002-2006). During his tenure at Georgetown he directed the successful competitive renewal of the Lombardi Comprehensive Cancer Center core grant in 2002, a doubling of the NCI grant base of the Center, developed a multi hospital clinical trials network, founded a cancer screening facility for underserved women with Andrea Jung and the Avon Foundation (March 9, 2004), a clinical cancer genetics screening program and developed new clinical translational research programs. He was the founding Director of the Delaware Valley Institute for Clinical and Translational Science (2008 - 2010), and is currently the Director of the Kimmel Cancer Center, Associate Dean and Vice President Oncology Services, Thomas Jefferson University and Hospital, Philadelphia. The Jefferson Cancer Network includes 22 institutions and hospitals in the Northeast of the United States. He founded the biotech company AAA Phoenix, was president of INCTR (USA) from 2005 - 2010.
Dr. Pestell has authored more than 575 published works, more than 367 original manuscripts and reviews, 23 book chapters and more than 170 published abstracts. His papers have been published in outstanding journals including Cell, Science, Nature Medicine, Molecular Cell and EMBO J. His work is highly cited (> 28,000 citations, H index 88 according to scHolar Index). In March 2002 he was ranked first in the world for increase in total scientific impact in biology and first in the world for biochemistry (ISI)
Maintained by the Informatics Shared Resources at the Kimmel Cancer Center at Jefferson
Copyright© Thomas Jefferson University. All Rights Reserved.
The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement